Event Brief
Jan 4, 2026 at 5:04 PM ET
FDA Approves First Oral Drug for Thalassemia Anaemia
By The BriefBrief
Mitapivat, an oral treatment for thalassemia, gains FDA approval, offering new hope for affected adults.
WHO: FDA
WHAT: Approved Mitapivat for thalassemia anaemia
WHEN: Jan 3, 2026 at 7:00 PM ET
WHERE: United States
WHY: To provide a novel treatment option for adults with thalassemia
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21439 of 21439
Same format. Every time.
Continue reading — sign in or create a free account with
